1′-acetoxychavicol acetate inhibits adipogenesis in 3T3-L1 adipocytes and in high fat-fed rats

American Journal of Chinese Medicine

Volumn 40, Issue 6, 2012, Pages 1189-1204

  Ohnishi, Rie ^a   Matsui Yuasa, Isao ^a,b   Deguchi, Yohei ^a   Yaku, Keisuke ^a   Tabuchi, Masaki ^c   Munakata, Hiroshi ^c   Akahoshi, Yasumitsu ^d   Kojima Yuasa, Akiko ^a  

^a Osaka Prefecture University   (Japan)

^b WAKAYAMA UNIVERSITY   (Japan)

^c KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d KINKI UNIVERSITY   (Japan)

Author keywords

1 Acetoxychavicol Acetate; 3T3 L1 Cell; AMP Activated Protein Kinase; GPDH; High Fat Diet Fed Rat; PPAR

Indexed keywords

1' ACETOXYCHAVICOL ACETATE; ACETIC ACID; ANTIOBESITY AGENT; CCAAT ENHANCER BINDING PROTEIN ALPHA; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; UNCLASSIFIED DRUG; 1'-ACETOXYCHAVICOL ACETATE; ADENYLATE KINASE; BENZYL ALCOHOL DERIVATIVE;

ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; DRUG EFFECT; EMBRYO; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; LIPID DIET; LIPID STORAGE; MALE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PROTEIN PHOSPHORYLATION; RAT; WEIGHT GAIN; ANIMAL; CELL STRAIN 3T3; FAT INTAKE; METABOLISM; MOUSE; PHOSPHORYLATION; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

3T3-L1 CELLS; ADENYLATE KINASE; ADIPOCYTES; ADIPOGENESIS; ANIMALS; BENZYL ALCOHOLS; BLOTTING, WESTERN; DIETARY FATS; MALE; MICE; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84871265104     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X12500887     Document Type: Article

References (43)

1. Brusq, J.M., N. Ancellin, P. Grondin, R. Guillaerd, S. Martin, Y. Saintillan and M. Issandou. Inhibition of lipid synthesis through activation of AMPK kinase: an additional mechanism for the hypolipidemic effects of berberine. J. Lipid Res. 47: 1281-1288, 2006.
2. Carling, D. The AMP-activated protein kinase cascade-a unifying system for energy control. Trends Biochem. Sci. 29: 18-24, 2004.
3. Despres, J.P. and I. Lemieux. Abnormal obesity and metabolic syndrome. Nature 444: 881-887, 2006.
4. Dominy, J.E., Y. Lee, Z. Gerhart-Hines and P. Puigserver. Nutrient-dependent regulation of PGC-1alpha's acetylation state and metabolic function through the enzymatic activities of Sirt1/GCN5. Biochim. Biophys. Acta 1804: 1676-1683, 2010.
5. ElJack, A.K., J.K. Hamm, P.F. Pilch and S.R. Farmer. Reconstitution of insulin-sensitive glucose transport in fibroblasts requires expression of both PPAR gamma and C/EBP alpha. J. Biol. Chem. 274: 7946-7951, 1999.
6. Fotakis, G. and J.A. Timbrell. In vitro cytotoxicity assays: comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to cadmium chloride. Toxicol. Lett. 160: 171-177, 2006.
7. Gao, Y., Y. Zhou, A. Xu and D. Wu. Effect of an AMP-activated protein kinase inhibitor, compound C, on adipogenic differentiation of 3T3-L1 cell. Biol. Pharm. Bull. 31: 1717-1722, 2008.
8. Hamm, J.K., B.H. Park and S.R. Farmer. A role for C/EBP beta in regulating peroxisome proliferatoractivated receptor gamma activity during adipogenesis in 3T3-L1 preadipocytes. J. Biol. Chem. 276: 18464-18471, 2001.
9. Hardie, D.G., S.A. Hawley and J.W. Scott. AMP-activated protein kinase-developing of the energy sensor concept. J. Physiol. 574: 7-15, 2006.
10. Huang, B., H.D. Yuan, D.Y. Kim, Y.Q. Hai and H.C. Sung. Cinnamaldehyde prevents adipocyte differentiation and adipogenesis via regulation of peroxisome proliferator-activated receptorgamma (PPAR gamma) and AMP-activated protein kinase (AMPK) pathways. J. Agric. Food Chem. 59: 3666-3673, 2011.
11. Huang, X., A. Kojima-Yuasa, T. Norikura, D.O. Kennedy, T. Hasumaand and I. Matsui-Yuasa. Mechanism of the anti-cancer activity of Zizyphusjujuba in HepG2 cells. Am. J. Chin. Med. 35: 517-532, 2007.
12. Hwang, J.T., I.J. Park, J.I. Shin, Y.K. Lee, S.K. Lee, H.W. Baik, J. Ha and O.J. Park. Genistein, EGCG, and capsaicin inhibit adipocyte differentiation process via activating AMP-activated protein kinase. Biochem. Biophys, Res. Commun. 338: 694-699, 2005.
13. Janssen, A.M. and J.J. Scheffer. Acetoxychavicil acetate, an antifungal component of Alpinia galanga. Planta Med. 51: 507-511, 1985.
14. Lee, S.J. and T. Ando. Optical active 10-acetoxychavicol acetate and its positional isomer: synthesis and repellent effect against adzuki bean weevil. J. Pestic. Sci. 26: 76-81, 2001.
15. Lee, Y.K., W.S. Lee, J.T. Hwang, D.Y. Kwon, Y.J. Surh and O.J. Park. Curcumin exerts antidifferentiation effect through AMPKa-PPARg in 3T3-L1 adipocytes and antiproliferatory effect through AMPKa-COX-2 in cancer cells. J. Agric. Food Chem. 57: 305-310, 2009.
16. Lieber, C.S., M.A. Leo, K.M. Mak, Y. Xu, Q. Cao, C. Ren, A. Ponomarenko and L.M. DeCarli. Model of nonalcoholic steatohepatiti. Am. J. Clin. Nutr. 79: 502-509, 2004.
17. Liu, X.M., K.J. Peyton, A.R. Shebib, H. Wang, R.J. Korthuis and W. Durante. Activation of AMPK stimulates heme oxygenase-1 gene expression and human endotherial cell survival. Am. J. Physiol. Heart Circ. Physiol. 300: H84-H93, 2011.
18. Liu, Y., R. Dentis, D. Chen, S. Hedrick, K. Ravnskjaer, S. Schenk, J. Milne, D.J. Meyers, P. Cole, J. Yates, J. Olefsky, L. Guarente and M. Montmimy. A fasting inducible switch modulators gluconeogenesis via activator/coactivator exchange. Nature 456: 269-273, 2008.
19. Matsuda, H., T. Moriwaki, H. Manago and M. Yoshikawa. Antiallergic principal from Alpinia galangal: structural requirements of phenylpropanoids for inhibition of degranulation and release of TNF-alpha and IL-4 in RBL-2H3 cells. Bioorg. Med. Chem. Lett. 13: 3197-3202, 2003.
20. Mitsui, S., S. Kobayashi, H. Nagahori and A. Ogiso. Constituents from seeds of Alpinia galangal wild and their antiulcer activities. Chem. Pharm. Bull. 24: 2377-2382, 1976.
21. Miyauchi, M., A. Nishikawa, F. Furukawa, H. Nakamura, H. Y. Son, A. Murakami, K. Koshimizu, H. Ohigashi and M. Hirose. Inhibitory effects of 10-acetoxychavicol acetate on N-nitrosobis(2-oxopropyl)-amine-induced initiation of cholangiocarcinogenesis in Syrian hamsters. Jpn. J. Cancer Res. 91: 477-481, 2000.
22. Moffatt, J.M., M. Hashimoto, A. Kojima, D.O. Kennedy, A. Murakami, K. Koshimizu, H. Ohigashi and I. Matsui-Yuasa. Apoptosis induced by 10-acetoxychavicol acetate in Ehrlich ascites tumor cells is associated with modulation of polyamine metabolism and caspasese activation. Carcinogenesis 21: 2151-2157, 2000.
23. Nakamura, Y., A. Murakami, Y. Ohta, K. Torikai, T. Tanaka and H. Ohigashi. Suppression of tumor promoter-induced oxidative stress and inflammatory responses in mouse skin by a superoxide generation inhibitor 10-acetoxychavocol acetate. Cancer Res. 58: 4832-4839, 1998.
24. Ohnishi, H., M. Asamoto, K. Tujimura, S. Hokaiwado, S. Takahashi, K. Ogawa, M. Kuribayashi, T. Ogiso, H. Okuyama and T. Shirai. Inhibition of cell proliferation by nobiletin, a dietary phytochemical, associated with apoptosis and characteristic gene expression, but lack of effect on early rat hepatocarcinogenesis in vivo. Cancer Sci. 95: 936-942, 2004.
25. Patsouris, D., S. Mandarard, P.J. Voshol, P. Escher, N.S. Tan, L.H. Havekes, W. Koenig, W. Marz, S. Tafuri, W. Washi, M. Muller and S. Kersten. PPARa governs glycerol metabolism. J. Clin. Invest. 114: 94-103, 2004.
26. Ramirez-Zacarias, J.L., F. Castro-Munozledo and W. Kuri-Harcuch. Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil red O. Histochemistry 97: 493-497, 1992.
27. Riddell, R.J., R.H. Clothier and M. Balls. An evaluation of three in vitro cytotoxicity assays. Food Chem. Toxicol. 24: 469-471, 1986.
28. Rodgers, J.T., C. Lerin, W. Haas, S.P. Gugi, B.M. Spiegelman and P. Puigserver. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 434: 113-118, 2005.
29. Smith, J., M. Al-Amiri, P. Dorairaj and A. Sniderman. The adipocyte life cycle hypothesis. Clin. Sci. (Lond.) 110: 1-9, 2006.
30. Spiegelman, B.M. and J.S. Flier. Obesity and the regulation of energy balance. Cell 104: 531-543, 2001.
31. Sundaresan, S., P. Vijayagopal, N. Mills, V. Imrhan and C. Prasad. A mouse model for nonalcoholic steatohepatitis. J. Nutr. Biochem. 22: 979-984, 2011.
32. Tilg, H. and A.R. Moschen. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat. Rev. Immunol. 6: 772-783, 2006.
33. Towler, M.C. and D.G. Hardie. AMP-activated protein kinase in metabolic control and insulin signaling. Circ. Res. 100: 328-341, 2007.
34. Unahara, Y., A. Kojima-Yuasa, M. Higashida, D. O. Kennedy, A. Murakami, H. Ohigashi and I. Matsui-Yuasa. Cellular thiol status-dependent inhibition of tumor cell growth via modulation of p27(kip1)translocation and retinoblastoma protein phosphorylation by 10-acetoxychavicol acetate. Amino Acids 33: 469-476, 2007.
35. Van den Berghe, G. The role of the liver in metabolichomeostesis: implication for inborn errors of metabolism. J. Inherit. Metab. Dis. 14: 407-420, 1991.
36. Wellen, K.E. and G.S. Hotamisligil. Inflammation, stress, and diabetes. J. Clin. Invest. 115: 1111-1119, 2005.
37. Wise, L.S. and H. Green. Participation of one isozyme of cytosolic glycerophosphate dehydrogenase in the adipose conversion of 3T3 cells. J. Biol. Chem. 254: 273-275, 1979.
38. Witczak, C.A., C.G. Sharoff and I.J. Goodyear. APM-activated protein kinase in skeletal muscle from structure and localization to its role as a master regulator of cellular metabolism. Cell. Mol. Life Sci. 65: 3737-3755, 2008.
39. Xu, S., A. Kojima-Yuasa, H. Azuma, X. Huang, T. Norikura, D.O. Kennedy and I. Matsui-Yuasa. (1′S)-Acetoxychavicol acetate and its enantiomer inhibit tumor cells proliferation via different mechanisms. Chem. Biol. Interact. 172: 216-223, 2008.
40. Yaku, K., I. Matsui-Yuasa, H. Azuma and A. Kojima-Yuasa. 1′-Acetoxuchavicol acetate enhances the phase II enzyme activities via the increase in intracellular Nrf2 level andcytosolic p21 level. Am. J. Chin. Med. 39: 789-802, 2011.
41. Yang, X. and R.G. Eilerman. Pungent Principal of Alpinia galangal (L.) Swartz and its applications. J. Agric. Food Chem. 47: 1657-1662, 1999.
42. Zhang, B.B., G. Zhou and C. Li. AMP, an emerging drug target for diabetes and the metabolic syndrome. Cell Metab. 9: 407-416, 2009.
43. Zheng, Q., Y. Hirose, N. Yoshimi, A. Murakami, K. Koshimizu, H. Ohigashi, K. Sakata, Y. Matsumoto, Y. Sayama and H. Mori. Further investigation of the modifying effect of various chemopreventive agents on apoptosis and cell proliferation in human colon cancer cells. J. Cancer Res. Clin. Oncol. 128: 539-546, 2002.